Respiratory Syncytial Virus (RSV) News and Research

RSS
Respiratory syncytial virus (RSV) causes mild, cold-like symptoms in adults and older children. However, it can cause serious problems in young babies, including pneumonia and severe breathing problems. In rare cases it can lead to death. Premature babies and those with other health problems have the highest risk. A child with RSV may have a fever, stuffy nose, cough and trouble breathing. Tests can tell if your child has the virus.
MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

Georgia State researcher receives grant to develop novel therapeutics against RSV infection

Georgia State researcher receives grant to develop novel therapeutics against RSV infection

Study finds ginseng can help prevent, treat influenza and RSV infection

Study finds ginseng can help prevent, treat influenza and RSV infection

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

Study reports benefits of implementing bronchiolitis guidelines at Children's Medical Center Dallas

Finding could lead to first effective vaccine against respiratory syncytial virus

Finding could lead to first effective vaccine against respiratory syncytial virus

TSRI scientists design artificial proteins as a candidate vaccine against RSV

TSRI scientists design artificial proteins as a candidate vaccine against RSV

Researchers design new vaccine for human-infecting respiratory syncytial virus

Researchers design new vaccine for human-infecting respiratory syncytial virus

Alere i Influenza A & B test now available in Europe

Alere i Influenza A & B test now available in Europe

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

New technique could help researchers unlock the secrets of respiratory syncytial virus

New technique could help researchers unlock the secrets of respiratory syncytial virus

Research finds reduced allergy risk among children raised with dogs from birth

Research finds reduced allergy risk among children raised with dogs from birth

Scientists identify genetic signature of respiratory syncytial virus

Scientists identify genetic signature of respiratory syncytial virus

Kentucky researcher uses advanced biomedical technology to study HMPV

Kentucky researcher uses advanced biomedical technology to study HMPV

Ablynx initiates additional Phase I studies with anti-RSV Nanobody ALX-0171

Ablynx initiates additional Phase I studies with anti-RSV Nanobody ALX-0171

International researchers solve three-dimensional structure of respiratory syncytial virus

International researchers solve three-dimensional structure of respiratory syncytial virus

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Children admitted in out-of-hours emergencies are at no greater risk of dying

Children admitted in out-of-hours emergencies are at no greater risk of dying

NIAID findings provide structural basis for developing RSV vaccine

NIAID findings provide structural basis for developing RSV vaccine

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

Study links genetic variation, wheezing illness to childhood asthma risk

Study links genetic variation, wheezing illness to childhood asthma risk